Results 221 to 230 of about 2,385,649 (308)

Selective Modulation of Trk Receptors by <i>Cyclo</i>-Organopeptides. [PDF]

ACS Chem Neurosci
Joy S, Mi T, Lyu RL, Pewklang T, Thompson T, Sefiani A, Kamkaew A, Burgess K.   +7 more
europepmc   +1 more source

Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma. [PDF]

CNS Oncol
Balasubramanian K, Fung KM, McNall-Knapp RY, Balsara K.   +3 more
europepmc   +1 more source

Neurotrophic factors as double-edged swords in osteosarcoma: drivers of tumour growth and immune remodelling. [PDF]

Front Immunol
Lei P, Li L.
europepmc   +1 more source

Neurotrophins (NT) modulate survival and chemotaxis in metastatic and primary melanoma cell lines through their high-affinity receptors Trk

, 2006
Francesca Truzzi, Alessandra Marconi, Roberta Lotti, Katiuscia Dallaglio, Marco Pignatti, Lars E. French, Carlo Pincelli   +6 more
openalex   +1 more source

Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer. [PDF]

Curr Oncol
Nagano H, Ohyama S, Sato A, Igarashi J, Yamamoto T, Kobayashi M.   +5 more
europepmc   +1 more source

Seven Shades of Triple Negativity: A Review Unveiling the Low-Grade Spectrum of Breast Cancer. [PDF]

Cancers (Basel)
Georgescu TA, Georgescu AC, Iacoban SR, Crețoiu D, Copca N, Olinca MV.   +5 more
europepmc   +1 more source

Correction to ‘Diminished trk A receptor signaling reveals cholinergic‐attentional vulnerability of aging’ [PDF]

openalex   +1 more source

Extraskeletal osteosarcoma harboring ETV6::NTRK3 fusion treated successfully with larotrectinib: a case study. [PDF]

Commun Med (Lond)
Skok K, Ochsenhofer F, Gassner R, Leithner A, Szkandera J, Viertler C, Hasenschwandtner S, Reichinger A, Liegl-Atzwanger B.   +8 more
europepmc   +1 more source

TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma. [PDF]

Int J Mol Sci
Ciarka A, Skowronek F, Miłosz P, Kunc M, Burdach R, Sakowicz-Burkiewicz M, Jereczek-Fossa B, Starzyńska A, Pęksa R.   +8 more
europepmc   +1 more source

Advances in Targeting Growth Factor Signalling in Neuroblastoma and Overcoming Drug Resistance. [PDF]

Cells
Ivanenko K, Shaymardanov R, Prassolov V, Lebedev T.   +3 more
europepmc   +1 more source